MK0893

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 1

A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED)

CompletedNCT00902161

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2009-05-31End: 2009-11-30Updated: 2015-07-03

Phase 2

Dose-Range Finding Study for MK0893 (0893-008)

TerminatedNCT00479466

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2007-07-31End: 2008-05-31Updated: 2015-09-09